Add to ORKGResearchers at Seoul National University Bundang and Children’s Hospitals, Republic of Korea evaluated the long-term effectiveness and tolerability of ethosuximide (ESX), valproic acid (VPA), and lamotrigine (LTG) as initial monotherapies for patients with childhood absence epilepsy (CAE)
In this short review, the challenges in the treatment of children with epilepsy are highlighted. It ...
Epilepsy is a chronic condition requiring long-term treatment with drugs that have intrinsic limitat...
We evaluated the efficacy and safety of lamotrigine in 41 children and young adults (age range, 3-25...
Purpose : We performed this study to evaluate the long-term efficacy and tolerability of ethosuximid...
Investigators from the Epilepsy Center, Lurie Children's Hospital of Chicago, and Yale School of Med...
This study was initiated to evaluate the long-term safety, tolerability and effect on seizure contro...
SummaryPurpose:Lamotrigine (LTG), vigabatrin (VGB) and gabapentin (GBP) are three anti-epileptic dru...
Efficacy, tolerability, and neuropsychological effects of ethosuximide, valproic acid, and lamotrigi...
AbstractPurposeIn order to estimate and compare the long-term effectiveness of lamotrigine (LTG) ver...
To evaluate and compare long-term effectiveness of five antiepileptic drugs (AEDs) for monotherapy o...
To evaluate and compare long-term effectiveness of five antiepileptic drugs (AEDs) for monotherapy o...
Lamotrigine (LTG) is an anti-epileptic drug effective in partial seizures and generalized epilepsy. ...
For children and adolescents with absence seizures, there was little or no evidence of a difference ...
With the pharmacotherapy of epilepsy, there is a decrease in the number of seizures or their complet...
A retrospective survey was carried out of add-on treatment with lamotrigine (LTG) and vigabatrin (GV...
In this short review, the challenges in the treatment of children with epilepsy are highlighted. It ...
Epilepsy is a chronic condition requiring long-term treatment with drugs that have intrinsic limitat...
We evaluated the efficacy and safety of lamotrigine in 41 children and young adults (age range, 3-25...
Purpose : We performed this study to evaluate the long-term efficacy and tolerability of ethosuximid...
Investigators from the Epilepsy Center, Lurie Children's Hospital of Chicago, and Yale School of Med...
This study was initiated to evaluate the long-term safety, tolerability and effect on seizure contro...
SummaryPurpose:Lamotrigine (LTG), vigabatrin (VGB) and gabapentin (GBP) are three anti-epileptic dru...
Efficacy, tolerability, and neuropsychological effects of ethosuximide, valproic acid, and lamotrigi...
AbstractPurposeIn order to estimate and compare the long-term effectiveness of lamotrigine (LTG) ver...
To evaluate and compare long-term effectiveness of five antiepileptic drugs (AEDs) for monotherapy o...
To evaluate and compare long-term effectiveness of five antiepileptic drugs (AEDs) for monotherapy o...
Lamotrigine (LTG) is an anti-epileptic drug effective in partial seizures and generalized epilepsy. ...
For children and adolescents with absence seizures, there was little or no evidence of a difference ...
With the pharmacotherapy of epilepsy, there is a decrease in the number of seizures or their complet...
A retrospective survey was carried out of add-on treatment with lamotrigine (LTG) and vigabatrin (GV...
In this short review, the challenges in the treatment of children with epilepsy are highlighted. It ...
Epilepsy is a chronic condition requiring long-term treatment with drugs that have intrinsic limitat...
We evaluated the efficacy and safety of lamotrigine in 41 children and young adults (age range, 3-25...